Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC)
Mohd Rais Mustafa, Kashif Abbas, Mudassir Alam, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 4, pp. 895-913
Closed Access | Times Cited: 18

Showing 18 citing articles:

Apoptosis: A Comprehensive Overview of Signaling Pathways, Morphological Changes, and Physiological Significance and Therapeutic Implications
Mohd Rais Mustafa, Rizwan Ahmad, Irfan Qadir Tantry, et al.
Cells (2024) Vol. 13, Iss. 22, pp. 1838-1838
Open Access | Times Cited: 25
The potential role of targeting the leptin receptor as a treatment for breast cancer in the context of hyperleptinemia: a literature review
Abbas S. Neamah, Al-Hassan Soliman Wadan, Fadhel M. Lafta, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 5
Discovery of Natural Resorcylic Acid Lactones as Novel Potent Copper Ionophores Covalently Targeting PRDX1 to Induce Cuproptosis for Triple-Negative Breast Cancer Therapy
Feng Li, Tizhi Wu, Xinxin Guo, et al.
ACS Central Science (2025) Vol. 11, Iss. 2, pp. 357-370
Open Access
Artificial Intelligence and Early Detection of Breast, Lung, and Colon Cancer: A Narrative Review
Omofolarin Debellotte, Richard L Dookie, Fnu Rinkoo, et al.
Cureus (2025)
Open Access
Discovery of a Novel 1,4-Benzodiazepine Derivative as a Highly Selective ANXA3 Degrader for the Treatment of Triple-Negative Breast Cancer
K. Liu, Chenhao Zhu, Yongxi Liang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Harnessing Artificial Intelligence for Precision Diagnosis and Treatment of Triple Negative Breast Cancer
Md Sadique Hussain, Prasanna Srinivasan Ramalingam, Gayathri Chellasamy, et al.
Clinical Breast Cancer (2025)
Closed Access
PFDN1 silencing disrupts critical cancer pathways in triple-negative breast cancer: investigating migration, cell cycle, and apoptosis as a new target therapy
Abdulrahman M. Alokda, Ahmed Soffar, Amany I. Yousef, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Role of PARP Inhibitors: A New Hope for Breast Cancer Therapy
K De, Malabendu Jana, Bhabadeb Chowdhury, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2773-2773
Open Access
Understanding the Molecular Mechanisms of SORBS2 in TNBC Lung Metastasis
Guizhen Zhao, Chunzheng Li, Wan Liu, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 762, pp. 151762-151762
Closed Access
Characterization of structural, genotoxic, and immunological effects of methyl methanesulfonate (MMS) induced DNA modifications: Implications for inflammation-driven carcinogenesis
Mohd Rais Mustafa, Safia Habib, Khalid Imtiyaz, et al.
International Journal of Biological Macromolecules (2024) Vol. 268, pp. 131743-131743
Closed Access | Times Cited: 3
Exploring the Influence of the Selected Conjugated Fatty Acids Isomers and Cancerous Process on the Fatty Acids Profile of Spleen
Tomasz Lepionka, Małgorzata Białek, M. Czauderna, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 479-479
Open Access | Times Cited: 2
Advancements in Clinical Research and Emerging Therapies for Triple-Negative Breast Cancer Treatment
Lili Xu, Pengtao Xu, Jingsong Wang, et al.
European Journal of Pharmacology (2024), pp. 177202-177202
Closed Access | Times Cited: 1
Identification of Hsp90 inhibitors from Ananas comosus potential phytochemicals for lung cancer treatment
Mudassir Alam, Kashif Abbas, Abrar Ahmad, et al.
The Journal of Phytopharmacology (2024) Vol. 13, Iss. 1, pp. 12-19
Open Access
Therapeutic Potential of PLK1, KIF4A, CDCA5, UBE2C, CDT1, SKA3, AURKB, and PTTG1 Genes in Triple-Negative Breast Cancer: Correlating Their Expression with Sensitivity to GSK 461364 and IKK 16 Drugs
Najmeh Bashari, Mohammadamin Naghizadeh, Mehrnaz Kalhor Chegini, et al.
Biochemical Genetics (2024)
Closed Access
A red cell membrane-camouflaged nanoreactor for enhanced starvation/chemodynamic/ion interference therapy for breast cancer
Junhao Zhang, Nan Chen, Luping Ren, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 245, pp. 114293-114293
Closed Access
Social epidemiology of female breast cancer in the region of Varna-Bulgaria in 2013-2021 – A retrospective study
Galina Yaneva, Tsonka Dimitrova, Oskan Tasinov
F1000Research (2024) Vol. 13, pp. 1137-1137
Open Access
Omega-3 Fatty Acids from Fish: A Novel Approach in Cancer Therapy
Kashif Abbas, Fatima Kamil, Yusra Tanveer, et al.
Biosciences Biotechnology Research Asia (2024) Vol. 21, Iss. 4, pp. 1303-1317
Open Access
Chronotherapeutic and Epigenetic Regulation of Circadian Rhythms: Nicotinamide Adenine Dinucleotide-Sirtuin Axis
Kashif Abbas, Rushda Sharf, Mudassir Alam, et al.
Journal of Sleep Medicine (2024) Vol. 21, Iss. 3, pp. 127-133
Open Access
Page 1

Scroll to top